Features
August 2010 Issue
Cardiovascular Risks Mount with Certain Anti-Inflammatory Drugs
Cardiovascular Risks Mount with Certain Anti-Inflammatory Drugs
A recent analysis of data from more than a million users of nonsteroidal anti-inflammatory drugs (NSAIDs) underscores the importance of careful selection and use of the medications, because they can vary widely in the risks they pose to patients. In the cohort study out of Denmark, the use of diclofenac (Cataflam, Voltaren) was associated with a 91 percent increase in the relative risk of a fatal heart attack or stroke in healthy adults.
To continue reading this entire article you must be a paid subscriber.
Subscribe to Heart Advisor
Heart Advisor is an informative monthly newsletter from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report.
Already subscribe but haven't registered for all the benefits of the website? Click here.
Subscriber Log In
Forgot your password? Click Here.